Drugs in Use

Drugs in Use
Author :
Publisher :
Total Pages : 0
Release :
ISBN-10 : 0853697914
ISBN-13 : 9780853697916
Rating : 4/5 (916 Downloads)

Book Synopsis Drugs in Use by : Linda J. Dodds

Download or read book Drugs in Use written by Linda J. Dodds and published by . This book was released on 2010 with total page 0 pages. Available in PDF, EPUB and Kindle. Book excerpt: This work is intended to offer guidance to pharmacists who need to bridge the gap between their theoretical knowledge and its practical application to individual patients.


Drugs in Use Related Books

Drugs in Use
Language: en
Pages: 0
Authors: Linda J. Dodds
Categories: Medical
Type: BOOK - Published: 2010 - Publisher:

DOWNLOAD EBOOK

This work is intended to offer guidance to pharmacists who need to bridge the gap between their theoretical knowledge and its practical application to individua
Drugs in Use
Language: en
Pages: 737
Authors: Linda J. Dodds
Categories: Medical
Type: BOOK - Published: 2013 - Publisher:

DOWNLOAD EBOOK

Drugs in Use is a popular textbook that addresses one of the key issues for pharmacy students - putting their learning into practice. The text presents a series
Drug Use for Grown-Ups
Language: en
Pages: 305
Authors: Dr. Carl L. Hart
Categories: Social Science
Type: BOOK - Published: 2022-01-11 - Publisher: Penguin

DOWNLOAD EBOOK

“Hart’s argument that we need to drastically revise our current view of illegal drugs is both powerful and timely . . . when it comes to the legacy of this
The Drugs We Love
Language: en
Pages: 192
Authors: Jerrold Winter PhD
Categories: Medical
Type: BOOK - Published: 2019-10-28 - Publisher: Oxford University Press

DOWNLOAD EBOOK

Prescription, illicit, and recreational drugs touch all of our lives yet a basic understanding of these chemicals is largely absent among Americans. Jerrold Win
The Risks of Prescription Drugs
Language: en
Pages: 179
Authors: Donald Light
Categories: Business & Economics
Type: BOOK - Published: 2010 - Publisher: Columbia University Press

DOWNLOAD EBOOK

Raises key questions about topics in the pharmaceutical industry, including how the risks of side effects are weighed, if privatization of that risk is prudent,